Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinoma.
Saved in:
| Title: | Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinoma. |
|---|---|
| Authors: | Standing D; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA., Arnold L; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA., Dandawate P; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA., Ottemann B; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas, USA., Snyder V; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas, USA., Ponnurangam S; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA., Sayed A; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA., Subramaniam D; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA., Srinivasan P; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA., Choudhury S; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA., New J; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas, USA.; Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, Kansas, USA., Kwatra D; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA., Ramamoorthy P; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA., Roy BC; Department of General Surgery, University of Kansas Medical Center, Kansas City, Kansas, USA., Shadoin M; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas, USA., Al-Rajabi R; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA., O'Neil M; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA., Gunewardena S; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas, USA., Ashcraft J; Department of General Surgery, University of Kansas Medical Center, Kansas City, Kansas, USA., Umar S; Department of General Surgery, University of Kansas Medical Center, Kansas City, Kansas, USA., Weir SJ; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.; Institute for Advancing Medical Innovation, University of Kansas Medical Center, Kansas City, Kansas, USA., Tawfik O; Department of Pathology, Saint Luke's Health System, Kansas City, Missouri, USA.; MAWD Pathology Group, Kansas City, Kansas, USA., Padhye SB; Department of Chemistry, Interdisciplinary Science and Technology Research Academy, University of Pune, Pune, India., Biersack B; Department of Chemistry, University of Bayreuth, Bayreuth, Germany., Anant S; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA., Thomas SM; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas, USA.; Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, Kansas, USA. |
| Source: | Molecular carcinogenesis [Mol Carcinog] 2023 Feb; Vol. 62 (2), pp. 145-159. Date of Electronic Publication: 2022 Oct 11. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36218231 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Standing+D%22">Standing D</searchLink>; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Arnold+L%22">Arnold L</searchLink>; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Dandawate+P%22">Dandawate P</searchLink>; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Ottemann+B%22">Ottemann B</searchLink>; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Snyder+V%22">Snyder V</searchLink>; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Ponnurangam+S%22">Ponnurangam S</searchLink>; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Sayed+A%22">Sayed A</searchLink>; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Subramaniam+D%22">Subramaniam D</searchLink>; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Srinivasan+P%22">Srinivasan P</searchLink>; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Choudhury+S%22">Choudhury S</searchLink>; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22New+J%22">New J</searchLink>; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas, USA.; Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Kwatra+D%22">Kwatra D</searchLink>; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Ramamoorthy+P%22">Ramamoorthy P</searchLink>; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Roy+BC%22">Roy BC</searchLink>; Department of General Surgery, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Shadoin+M%22">Shadoin M</searchLink>; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Al-Rajabi+R%22">Al-Rajabi R</searchLink>; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22O'Neil+M%22">O'Neil M</searchLink>; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Gunewardena+S%22">Gunewardena S</searchLink>; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Ashcraft+J%22">Ashcraft J</searchLink>; Department of General Surgery, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Umar+S%22">Umar S</searchLink>; Department of General Surgery, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Weir+SJ%22">Weir SJ</searchLink>; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.; Institute for Advancing Medical Innovation, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Tawfik+O%22">Tawfik O</searchLink>; Department of Pathology, Saint Luke's Health System, Kansas City, Missouri, USA.; MAWD Pathology Group, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Padhye+SB%22">Padhye SB</searchLink>; Department of Chemistry, Interdisciplinary Science and Technology Research Academy, University of Pune, Pune, India.<br /><searchLink fieldCode="AU" term="%22Biersack+B%22">Biersack B</searchLink>; Department of Chemistry, University of Bayreuth, Bayreuth, Germany.<br /><searchLink fieldCode="AU" term="%22Anant+S%22">Anant S</searchLink>; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+SM%22">Thomas SM</searchLink>; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas, USA.; Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, Kansas, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228811105%22">Molecular carcinogenesis</searchLink> [Mol Carcinog] 2023 Feb; Vol. 62 (2), pp. 145-159. <i>Date of Electronic Publication: </i>2022 Oct 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8811105 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1098-2744 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208991987%22">08991987 </searchLink><i>NLM ISO Abbreviation: </i>Mol Carcinog <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36218231 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/mc.23472 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 145 Titles: – TitleFull: Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Standing D – PersonEntity: Name: NameFull: Arnold L – PersonEntity: Name: NameFull: Dandawate P – PersonEntity: Name: NameFull: Ottemann B – PersonEntity: Name: NameFull: Snyder V – PersonEntity: Name: NameFull: Ponnurangam S – PersonEntity: Name: NameFull: Sayed A – PersonEntity: Name: NameFull: Subramaniam D – PersonEntity: Name: NameFull: Srinivasan P – PersonEntity: Name: NameFull: Choudhury S – PersonEntity: Name: NameFull: New J – PersonEntity: Name: NameFull: Kwatra D – PersonEntity: Name: NameFull: Ramamoorthy P – PersonEntity: Name: NameFull: Roy BC – PersonEntity: Name: NameFull: Shadoin M – PersonEntity: Name: NameFull: Al-Rajabi R – PersonEntity: Name: NameFull: O'Neil M – PersonEntity: Name: NameFull: Gunewardena S – PersonEntity: Name: NameFull: Ashcraft J – PersonEntity: Name: NameFull: Umar S – PersonEntity: Name: NameFull: Weir SJ – PersonEntity: Name: NameFull: Tawfik O – PersonEntity: Name: NameFull: Padhye SB – PersonEntity: Name: NameFull: Biersack B – PersonEntity: Name: NameFull: Anant S – PersonEntity: Name: NameFull: Thomas SM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2023 Feb Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1098-2744 Numbering: – Type: volume Value: 62 – Type: issue Value: 2 Titles: – TitleFull: Molecular carcinogenesis Type: main |
| ResultId | 1 |